Retraction
Anti-microRNA-222 (anti-miR-222) and -181B suppresses growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal
Paper Information
Record ID:
17572
Author(s):
Journal:
Publication Date:
October 18, 2011
Retraction Date:
February 13, 2018
(7.8 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, Ohio 43210 Department of Pathology, The Ohio State University, Columbus, Ohio 43210
- Department of Internal Medicine, The Ohio State University, Columbus, Ohio 43210
- Department of Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Society for Biochemistry and Molecular Biology (ASBMB)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed
Retraction Details
Citations (97)
97
Total Citations22
Post-Retraction(22.7%)
67
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
7
Within 1 year
11
After 2+ years
2023
Days since retraction (latest)
RETRACTED: miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway
Bailong Li, Ying Lü, Honghai Wang et al. (11 authors)
Biomedicine & Pharmacotherapy
Published: Feb 2016
89 citations
89 citations
727 days before retraction
Paper citing Gemcitabine Sensitivity Can Be Induced in Pancreat...
Unknown Authors
Unknown Journal
Published: Dec 2015
780 days before retraction
Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease
Zdeňka Navrátilová, Vı́tězslav Kolek, Martin Petřek
Archivum Immunologiae et Therapiae Experimentalis
Published: Nov 2015
68 citations
68 citations
810 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Oct 2015
853 days before retraction
Paper citing MicroRNAs in Cancer...
Unknown Authors
Unknown Journal
Published: Oct 2015
854 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Oct 2015
866 days before retraction
Timp3 Deficient Mice Show Resistance to Developing Breast Cancer
Hartland W. Jackson, Carlo Hojilla, Ashley Weiss et al. (6 authors)
PLoS ONE
Open Access
Published: Mar 2015
25 citations
25 citations
1056 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Mar 2015
1063 days before retraction
MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2
Fan Yang, Wei Wang, Chunhui Zhou et al. (10 authors)
Tumor Biology
Published: Mar 2015
84 citations
84 citations
1079 days before retraction
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets
Carolyn M. Klinge
Molecular and Cellular Endocrinology
Open Access
Published: Feb 2015
102 citations
102 citations
1106 days before retraction
MicroRNAs and Cancer
Stephen G. Maher, B. Bibby, Hannah Moody et al. (4 authors)
Elsevier eBooks
Published: Jan 2015
1 citation
1 citation
1139 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Oct 2014
1223 days before retraction
miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
Kai Liu, Songyang Liu, Wei Zhang et al. (6 authors)
International Journal of Oncology
Open Access
Published: Aug 2014
48 citations
48 citations
1289 days before retraction
Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3
Rong Gan, Yi Yang, Xiaojiao Yang et al. (6 authors)
Cancer Gene Therapy
Open Access
Published: Jun 2014
113 citations
113 citations
1341 days before retraction
Down-Regulation of mir-221 and mir-222 Restrain Prostate Cancer Cell Proliferation and Migration That Is Partly Mediated by Activation of SIRT1
Yang Xiao, Yingmei Yang, Rong Gan et al. (9 authors)
PLoS ONE
Open Access
Published: Jun 2014
85 citations
85 citations
1351 days before retraction
MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain
Q. Li, Jianxun Wang, YQ He et al. (7 authors)
Cell Death and Disease
Open Access
Published: Apr 2014
85 citations
85 citations
1391 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Apr 2014
1399 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Mar 2014
1445 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Jan 2014
1477 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Jan 2014
1504 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Nov 2013
1544 days before retraction
miR‐181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells
Lei Yang, Yanli Wang, Shang Liu et al. (7 authors)
FEBS Letters
Published: Nov 2013
73 citations
73 citations
1546 days before retraction
miRNA Dysregulation in Breast Cancer
Laoighse Mulrane, Sharon F. McGee, William M. Gallagher et al. (4 authors)
Cancer Research
Open Access
Published: Nov 2013
256 citations
256 citations
1558 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Aug 2013
1646 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Jul 2013
1688 days before retraction
Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221
Ying Li, Mei Liu, Yanjun Zhang et al. (8 authors)
Tumor Biology
Published: Jun 2013
19 citations
19 citations
1694 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Jun 2013
1694 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Jun 2013
1702 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Jun 2013
1706 days before retraction
Paper citing Anti-Tumor Activity of a Novel Compound-CDF Is Med...
Unknown Authors
Unknown Journal
Published: Jun 2013
1718 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: May 2013
1745 days before retraction
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells
Rounak Nassirpour, Pramod P. Mehta, Sangita M. Baxi et al. (4 authors)
PLoS ONE
Open Access
Published: Apr 2013
93 citations
93 citations
1756 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Apr 2013
1762 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Apr 2013
1779 days before retraction
miR-221/222: promising biomarkers for breast cancer
Wei‐xian Chen, Qing Hu, Mantang Qiu et al. (7 authors)
Tumor Biology
Published: Mar 2013
114 citations
114 citations
1785 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Mar 2013
1789 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Feb 2013
1817 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Feb 2013
1818 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Feb 2013
1819 days before retraction
MicroRNAs in Cancer
Jianzhong Xi
Cancer treatment and research
Published: Jan 2013
28 citations
28 citations
1869 days before retraction
Therapeutic Evaluation of microRNAs by Molecular Imaging
Thillai V. Sekar, Kunka Mohanram Ramkumar, Kira Foygel et al. (4 authors)
Theranostics
Open Access
Published: Jan 2013
23 citations
23 citations
1869 days before retraction
MicroRNAs in Cell Death and Cancer
Jong Kook Park, Thomas D. Schmittgen
Springer eBooks
Published: Nov 2012
1 citation
1 citation
1915 days before retraction
Promoter hypermethylation contributes to <scp><scp>TIMP</scp></scp><i>3</i> down‐regulation in high stage endometrioid endometrial carcinomas
Lluís Catasús, Cristina Pons, Josefina Muñoz et al. (5 authors)
Histopathology
Published: Oct 2012
19 citations
19 citations
1946 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Sep 2012
1967 days before retraction
Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
Bhuvaneswari Ramaswamy, Yuanzhi Lu, Kun‐Yu Teng et al. (7 authors)
Cancer Research
Open Access
Published: Aug 2012
186 citations
186 citations
2014 days before retraction
Paper citing Anti-microRNA-222 (anti-miR-222) and -181B suppres...
Unknown Authors
Unknown Journal
Published: Mar 2012
2175 days before retraction
Paper citing Anti-Tumor Activity of a Novel Compound-CDF Is Med...
Unknown Authors
Unknown Journal
Published: Feb 2012
2188 days before retraction
Quick Stats
Total Citations:
97
Years Since Retraction:
7.8 years
Open Access:
Yes
Last Checked:
Never